Glycosylation as a key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2

The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its spread since 2019 represents the major public health problem worldwide nowadays, generating a high number of infections and deaths. That’s why, in addition to vaccination campaigns, the design of a drug to help...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Georcki Ropón‐Palacios, Jhon Pérez-Silva, Ricardo Rojas-Humpire, Gustavo E. Olivos-Ramírez, Manuel Enrique Chenet Zuta, Víctor Villanueva, Sheyla Carmen-Sifuentes, Kewin Otazu, Yaritza L. Ramirez-Díaz, Ihosvany Camps
Formato:	Preprint
Lenguaje:	inglés
Publicado:	2021
Materias:	Glycosylation Glycoprotein Computational biology Drug Biology Protein folding Chemistry Cell biology Virology Genetics Pharmacology Health Sciences Medicine Infectious Diseases SARS-CoV-2 and COVID-19 Research Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology vaccines and immunoinformatics approaches Health Sciences Medicine Radiology, Nuclear Medicine and Imaging Monoclonal and Polyclonal Antibodies Research
Acceso en línea:	Descargar el archivo Enlace permanente (DOI o Handle) Enlace permanente (DOI o Handle)
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Glycosylation as a key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2

Ejemplares similares